Assembly Biosciences Inc logo

Assembly Biosciences Inc

$ 1.30 -0.02 (-1.52%) 10:08 PM EST
P/E:
At Loss
P/B:
0.62
Market Cap:
$ 63.41M
Enterprise V:
$ -39.97M
Volume:
131.39K
Avg Vol (2M):
202.63K
Also Trade In:
Volume:
131.39K
Market Cap $:
63.41M
PE Ratio:
At Loss
Avg Vol (2-Month):
202.63K
Enterprise Value $:
-39.97M
PB Ratio:
0.62
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Name Current Vs Industry Vs History
Cash-To-Debt 25.33
Equity-to-Asset 0.84
Debt-to-Equity 0.04
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -6
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.14
9-Day RSI 35.39
14-Day RSI 36.08
6-1 Month Momentum % -14.51
12-1 Month Momentum % -29.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.44
Quick Ratio 7.44
Cash Ratio 7.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.6

Financials (Next Earnings Date:2023-03-10 Est.)

ASMB's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ASMB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.84
Beta 0.44
Volatility % 56.5
14-Day RSI 36.08
14-Day ATR ($) 0.095739
20-Day SMA ($) 1.429
12-1 Month Momentum % -29.79
52-Week Range ($) 1.2 - 2.45
Shares Outstanding (Mil) 48.78

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Assembly Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Assembly Biosciences Inc Analysis

Share your research

Headlines

See More
No news.